Sunday, October 24, 2021

Treatment enhances anti-leukemia effect of bone marrow transplant, reduces recurrence, study finds

Researchers have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20% among the high-risk patients.

from Top Health News -- ScienceDaily https://ift.tt/3Ca8R97
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

FDA clears IND for clinical trial testing switchable CAR-T therapy in patients with autoimmune diseases, without chemotherapy

FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001...